Cargando…

Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative

BACKGROUND: Non‐alcoholic fatty liver disease (NAFLD), prediabetes and type 2 diabetes mellitus are known to be closely linked with obesity as early as during childhood. OBJECTIVES: The study aimed to determine the prevalence of prediabetes and T2DM in children with obesity with or without increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutny, Florian, Weghuber, Daniel, Bollow, E., Greber‐Platzer, S., Hartmann, K., Körner, A., Reinehr, T., Roebl, M., Simic‐Schleicher, G., Wabitsch, M., Widhalm, K., Wiegand, S., Holl, R. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079233/
https://www.ncbi.nlm.nih.gov/pubmed/31810110
http://dx.doi.org/10.1111/ijpo.12601
_version_ 1783507785942564864
author Koutny, Florian
Weghuber, Daniel
Bollow, E.
Greber‐Platzer, S.
Hartmann, K.
Körner, A.
Reinehr, T.
Roebl, M.
Simic‐Schleicher, G.
Wabitsch, M.
Widhalm, K.
Wiegand, S.
Holl, R. W.
author_facet Koutny, Florian
Weghuber, Daniel
Bollow, E.
Greber‐Platzer, S.
Hartmann, K.
Körner, A.
Reinehr, T.
Roebl, M.
Simic‐Schleicher, G.
Wabitsch, M.
Widhalm, K.
Wiegand, S.
Holl, R. W.
author_sort Koutny, Florian
collection PubMed
description BACKGROUND: Non‐alcoholic fatty liver disease (NAFLD), prediabetes and type 2 diabetes mellitus are known to be closely linked with obesity as early as during childhood. OBJECTIVES: The study aimed to determine the prevalence of prediabetes and T2DM in children with obesity with or without increased transaminases. METHODS: Data from the observational multicentre (n = 51), cross‐sectional Adipositas Patienten Verlaufsbeobachtung registry were analyzed. Mild increase (mild group) was defined by alanine transaminase (ALT) >24 to ≤50 U/L and moderate to severe increase (advanced group) by ALT > 50 U/L. Prediabetes and T2DM were defined according to recent IDF/ISPAD guidelines. RESULTS: The prevalence of prediabetes and T2DM was 11.9% (95% CI: 11.0–12.8) and 1.4% (95% CI: 1.1–1.7) among all participants (n = 4932; male = 2481; mean age 12.9 ± 2.7 years; BMI‐SDS 2.1 ± 0.5; Tanner stage 3.2 ± 1.5). The prevalence of impaired glucose metabolism (prediabetes and T2DM) was 13.8% (95% CI: 12.1–15.4) in the mild, 21.9% (95% CI: 18.8–25.1) in the advanced group, 10.7% (95% CI: 9.4–11.9) in the control group. Mild and advanced groups had greater odds ratios for prediabetes [1.42; 95% CI: 1.17–1.72, 2.26‐fold; (1.78–2.86), respectively], the advanced group also for T2DM [2.39 (1.36–4.21)] compared to controls. While an increase in transaminases predominantly affected boys, girls within the advanced group had a higher T2DM prevalence than males (5.4 vs. male 2.1%). CONCLUSIONS: Children with obesity and increased liver transaminases as surrogates of NAFLD should be screened for T2DM.
format Online
Article
Text
id pubmed-7079233
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70792332020-03-19 Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative Koutny, Florian Weghuber, Daniel Bollow, E. Greber‐Platzer, S. Hartmann, K. Körner, A. Reinehr, T. Roebl, M. Simic‐Schleicher, G. Wabitsch, M. Widhalm, K. Wiegand, S. Holl, R. W. Pediatr Obes Original Research BACKGROUND: Non‐alcoholic fatty liver disease (NAFLD), prediabetes and type 2 diabetes mellitus are known to be closely linked with obesity as early as during childhood. OBJECTIVES: The study aimed to determine the prevalence of prediabetes and T2DM in children with obesity with or without increased transaminases. METHODS: Data from the observational multicentre (n = 51), cross‐sectional Adipositas Patienten Verlaufsbeobachtung registry were analyzed. Mild increase (mild group) was defined by alanine transaminase (ALT) >24 to ≤50 U/L and moderate to severe increase (advanced group) by ALT > 50 U/L. Prediabetes and T2DM were defined according to recent IDF/ISPAD guidelines. RESULTS: The prevalence of prediabetes and T2DM was 11.9% (95% CI: 11.0–12.8) and 1.4% (95% CI: 1.1–1.7) among all participants (n = 4932; male = 2481; mean age 12.9 ± 2.7 years; BMI‐SDS 2.1 ± 0.5; Tanner stage 3.2 ± 1.5). The prevalence of impaired glucose metabolism (prediabetes and T2DM) was 13.8% (95% CI: 12.1–15.4) in the mild, 21.9% (95% CI: 18.8–25.1) in the advanced group, 10.7% (95% CI: 9.4–11.9) in the control group. Mild and advanced groups had greater odds ratios for prediabetes [1.42; 95% CI: 1.17–1.72, 2.26‐fold; (1.78–2.86), respectively], the advanced group also for T2DM [2.39 (1.36–4.21)] compared to controls. While an increase in transaminases predominantly affected boys, girls within the advanced group had a higher T2DM prevalence than males (5.4 vs. male 2.1%). CONCLUSIONS: Children with obesity and increased liver transaminases as surrogates of NAFLD should be screened for T2DM. John Wiley and Sons Inc. 2019-12-06 2020-04 /pmc/articles/PMC7079233/ /pubmed/31810110 http://dx.doi.org/10.1111/ijpo.12601 Text en © 2019 The Authors. Pediatric Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Koutny, Florian
Weghuber, Daniel
Bollow, E.
Greber‐Platzer, S.
Hartmann, K.
Körner, A.
Reinehr, T.
Roebl, M.
Simic‐Schleicher, G.
Wabitsch, M.
Widhalm, K.
Wiegand, S.
Holl, R. W.
Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative
title Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative
title_full Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative
title_fullStr Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative
title_full_unstemmed Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative
title_short Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative
title_sort prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in european german‐speaking countries. analysis of the apv initiative
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079233/
https://www.ncbi.nlm.nih.gov/pubmed/31810110
http://dx.doi.org/10.1111/ijpo.12601
work_keys_str_mv AT koutnyflorian prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT weghuberdaniel prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT bollowe prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT greberplatzers prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT hartmannk prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT kornera prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT reinehrt prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT roeblm prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT simicschleicherg prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT wabitschm prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT widhalmk prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT wiegands prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative
AT hollrw prevalenceofprediabetesandtype2diabetesinchildrenwithobesityandincreasedtransaminasesineuropeangermanspeakingcountriesanalysisoftheapvinitiative